Therefore, the fact that RVL completely abrogated the increase of hepatic blood IL-18 induced by tumor-derived factors suggests the potential use of RVL as a hepatic metastasis chemopreventive agent in cancer patients at high risk of hepatic metastasis, such as those suffering from a malignant uveal melanoma. Here, IL18 is linked to uveal melanoma.